A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Clinical trial NCT01928147 · COMPLETED

Trial details

NCT number: NCT01928147
Sponsor: Presidio Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2013-08-01
Primary completion: 2015-07-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.